📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
52
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
50%
💰 Capital Raise
55%
• Critical: only 0.3 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔁 Convertible Conversion
40%
• Significant convertible debt: 18% potential dilution
• Elevated convertible risk (60/100)
💹 Market Data
Market Cap$16.51M
Shares Outstanding8.21M
Float4.71M
Cash$266.4K
Debt$7.63M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 107.6% shares (2025Q4 vs prior)
7 institutional holders · 124.6K shares
#1
DRW Securities, LLC
65.0K shares
#2
VANGUARD GROUP INC
33.1K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
23.3K shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest93.6K
Days to Cover1.4
% of Float2.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Sep 30, 2025
3
FORM3
Apr 07, 2026
8-K
8K EVENT
Apr 06, 2026
3
FORM3
Mar 25, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for REBN
📊 REBN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 REBN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.